Klotho Neurosciences (NASDAQ:KLTO) Announces Earnings Results

Klotho Neurosciences (NASDAQ:KLTO) released its quarterly earnings results on Monday. The company reported ($0.07) earnings per share (EPS) for the quarter, Zacks reports.

Klotho Neurosciences Stock Performance

Shares of KLTO stock opened at $0.23 on Wednesday. Klotho Neurosciences has a twelve month low of $0.21 and a twelve month high of $13.10. The firm’s 50-day moving average price is $0.33.

Klotho Neurosciences Company Profile

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.